Re: CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women With Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial.
摘要:
The author discusses a study by M. M. Regan et al on CYP2D6 genotype and tamoxifen response in postmenopausal women with breast cancer. He suggests the serious doubts about conclusions raised by the implausible CYP2DC6 genotyping results from the Breast International Group 1-98 trial. He notes that the area representative of the invasive tumor component should have been avoided in the study. He also cites the lack of genotype data to evaluate the methodological problems that occurred.
展开
DOI:
10.1093/jnci/djs305
被引量:
年份:
2012






通过文献互助平台发起求助,成功后即可免费获取论文全文。
请先登入
相似文献
参考文献
引证文献
引用走势
2013
被引量:107
辅助模式
0
引用
文献可以批量引用啦~
欢迎点我试用!